Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Velligan, D. I. Articles by Miller, A. L. Search for Related Content PubMed Citation Articles by Velligan, D. I. Articles by Miller, A. L. Treatment Compliance Other Health Services Issues Schizophrenia Spectrum Disorders Atypical Neuroleptics Conventional Neuroleptics Related Article

Relationships Among Subjective and Objective Measures of Adherence to Oral Antipsychotic Medications

OBJECTIVE: The most common ways of assessing adherence to oral antipsychotic medications in research and in clinical practice are self-report and physician report. This prospective study examined the agreement among measures of adherence to oral antipsychotic medications among 52 outpatients with schizophrenia. METHODS: Participants were assessed at baseline during a visit to their outpatient clinic and followed for 12 weeks. Adherence was assessed by using subjective measures (self-report and physician report) and objective measures (pill counts conducted in the home, electronic monitoring, and blood plasma concentrations). Electronic monitoring was used as an imperfect standard against which other methods were judged. RESULTS: Data from pill counts and from electronic monitoring were strongly correlated (r_k=.61). Self-report and physicians' ratings of compliance were weakly correlated with pill count and electronic monitoring when compliance scores were examined with rank-order correlations (r_k=.18–.32). When the sample was dichotomized into adherent and nonadherent groups on the basis of electronic monitoring or pill count (at least 80% adherent), neither physicians nor patients identified adherent behavior (kappa20). Blood plasma concentrations were not correlated with any other measures of adherence (kappa20). Self-report and physician report were best correlated with clinical state (r_k=-.27, r_k=-.25), suggesting that patients and treating professionals may use clinical state to estimate adherence. CONCLUSIONS: Patients and physicians were not able to identify adherence. The inability of physicians to accurately identify adherent individuals is likely to have important consequences for prescribing behavior, health care costs, and patient outcomes.

Related Article:

September 2007: This Month's Highlights
Psychiatr Serv 2007 58: 1147. [Full Text] [PDF]

This article has been cited by other articles:

				D. I. Velligan, P. M. Diamond, J. Mintz, N. Maples, X. Li, J. Zeber, L. Ereshefsky, Y.-W. F. Lam, D. Castillo, and A. L. Miller The Use of Individually Tailored Environmental Supports to Improve Medication Adherence and Outcomes in Schizophrenia Schizophr Bull, May 1, 2008; 34(3): 483 - 493. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2007 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us